A Phase 1b Proof-of-concept Trial Exploring the Effects of FE 999322 and FE 999324 in Adults With Mild to Moderate Ulcerative Colitis

Conditions: Ulcerative Colitis Interventions: Drug: Microbiota suspension; Drug: Microbiota capsule; Drug: Placebo suspension; Drug: Placebo capsule Sponsors: Ferring Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials